Armata Pharmaceuticals's market cap is currently $76.17M. The company's EPS TTM is $-1.641; its P/E ratio is ―; Armata Pharmaceuticals is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 4.53M	$ 5.51M	$ 4.47M	$ 823.00K	$ 0.00
Gross Profit	$ -29.24M	$ 4.62M	$ -15.54M	$ -13.62M	$ -1.35M
Operating Income	$ -40.89M	$ -36.95M	$ -23.82M	$ -21.59M	$ -19.75M
EBITDA	$ -39.92M	$ -36.05M	$ -22.65M	$ -20.44M	$ -19.75M
Net Income	$ -69.05M	$ -36.89M	$ -23.22M	$ -22.82M	$ -19.02M
Balance Sheet
Cash & Short-Term Investments	$ 13.52M	$ 14.85M	$ 10.29M	$ 9.65M	$ 6.03M
Total Assets	$ 98.36M	$ 95.83M	$ 69.77M	$ 39.52M	$ 25.45M
Total Debt	$ 120.37M	$ 48.81M	$ 37.99M	$ 13.15M	$ 2.86M
Net Debt	$ 106.85M	$ 33.96M	$ 27.70M	$ 3.50M	$ -3.17M
Total Liabilities	$ 130.43M	$ 59.75M	$ 44.37M	$ 20.66M	$ 10.86M
Stockholders' Equity	$ -32.06M	$ 36.08M	$ 25.40M	$ 18.86M	$ 14.59M
Cash Flow
Free Cash Flow	$ -55.57M	$ -34.69M	$ -24.88M	$ -19.09M	$ -15.71M
Operating Cash Flow	$ -47.42M	$ -32.48M	$ -23.57M	$ -18.27M	$ -15.58M
Investing Cash Flow	$ -8.13M	$ -2.21M	$ -1.30M	$ -824.00K	$ 2.88M
Financing Cash Flow	$ 53.99M	$ 44.02M	$ 25.52M	$ 23.21M	$ 8.97M

Currency in USD

Armata Pharmaceuticals Earnings and Revenue History

Income Statement >

Armata Pharmaceuticals Debt to Assets

Balance Sheet >

Armata Pharmaceuticals Cash Flow

Cash Flow >

Armata Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing